Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
- PMID: 16606677
- PMCID: PMC2118281
- DOI: 10.1084/jem.20060218
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
Abstract
Oxidation of low-density lipoprotein (LDL) is thought to contribute to atherosclerosis and cardiovascular disease. Consistent with this idea, the antioxidant drug probucol reduces the risk of restenosis, a form of cardiovascular disease, in humans. However, a new study now suggests that the protective effect of probucol depends not on its ability to inhibit lipid oxidation, but on its ability to induce the stress-induced antiinflammatory enzyme heme oxygenase (HO)-1. This might explain why other antioxidants, such as vitamin E, fail to prevent cardiovascular disease in humans.
Figures


Comment on
-
Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.J Exp Med. 2006 Apr 17;203(4):1117-27. doi: 10.1084/jem.20052321. Epub 2006 Apr 10. J Exp Med. 2006. PMID: 16606673 Free PMC article.
Similar articles
-
Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.Kidney Int. 1997 Apr;51(4):1151-9. doi: 10.1038/ki.1997.158. Kidney Int. 1997. PMID: 9083281
-
Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.Am J Cardiol. 1994 Jul 1;74(1):38-42. doi: 10.1016/0002-9149(94)90488-x. Am J Cardiol. 1994. PMID: 8017303
-
Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.Crit Rev Food Sci Nutr. 1995 Jan;35(1-2):83-98. doi: 10.1080/10408399509527689. Crit Rev Food Sci Nutr. 1995. PMID: 7748483 Review.
-
Inhibition of lipoprotein lipid oxidation.Handb Exp Pharmacol. 2005;(170):563-90. doi: 10.1007/3-540-27661-0_21. Handb Exp Pharmacol. 2005. PMID: 16596815 Review.
-
Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.Mol Cell Biochem. 2003 Jul;249(1-2):129-40. Mol Cell Biochem. 2003. PMID: 12956408
Cited by
-
Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Antioxid Redox Signal. 2010 Jul 1;13(1):39-75. doi: 10.1089/ars.2009.2733. Antioxid Redox Signal. 2010. PMID: 19888833 Free PMC article. Review.
-
Foam Cell Induction Activates AMPK But Uncouples Its Regulation of Autophagy and Lysosomal Homeostasis.Int J Mol Sci. 2020 Nov 27;21(23):9033. doi: 10.3390/ijms21239033. Int J Mol Sci. 2020. PMID: 33261140 Free PMC article.
-
Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.Sex Med Rev. 2019 Oct;7(4):604-613. doi: 10.1016/j.sxmr.2019.05.005. Epub 2019 Jul 17. Sex Med Rev. 2019. PMID: 31326360 Free PMC article. Review.
-
Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles.PLoS One. 2013;8(1):e55198. doi: 10.1371/journal.pone.0055198. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383107 Free PMC article.
-
Association between dietary vitamin E intake and incident cardiovascular disease, cardiovascular, and all-cause mortality: A prospective cohort study using NHANES 2003-2018 data.Int J Cardiol Cardiovasc Risk Prev. 2024 Oct 18;24:200340. doi: 10.1016/j.ijcrp.2024.200340. eCollection 2025 Mar. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39790118 Free PMC article.
References
-
- Heinecke, J.W. 1998. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1–15. - PubMed
-
- Morel, D.W., P.E. DiCorleto, and G.M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:357–364. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical